SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-15-000020
Filing Date
2015-01-08
Accepted
2015-01-07 21:19:54
Documents
3
Period of Report
2015-01-08
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k010715_delmarpharma.htm 8-K 21881
2 EXHIBIT 99.1 f8k010715ex99i_delmarpharma.htm EX-99.1 11686
3 GRAPHIC image_002.jpg GRAPHIC 8043
  Complete submission text file 0001013762-15-000020.txt   46095
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54801 | Film No.: 15514766
SIC: 2834 Pharmaceutical Preparations